15 July 2026CompletedHealthcare
GSK plc to acquire Nuvalent, Inc
GSK plc and Nuvalent, Inc entered the Exit Mode archive.
- Buyer
- GSK plc
- Target
- Nuvalent, Inc
- Deal value
- USD 10,600,000,000
- Deal type
- strategic acquisition
Buyer profile
GSK plc
Every published deal in the Exit Mode archive where this buyer appears on the acquiring side.
Country
United Kingdom
Deal count
3
Buyer type
Corporate / other
Aggregate disclosed value
Not stated
15 April 2026CompletedHealthcare
GSK plc to acquire 35Pharma Inc.
GSK plc and 35Pharma Inc. entered the Exit Mode archive.
- Buyer
- GSK plc
- Target
- 35Pharma Inc.
- Deal value
- USD 950,000,000
- Deal type
- strategic acquisition
12 April 2022CompletedHealthcare
GSK plc to acquire Sierra Oncology, Inc.
GSK plc and Sierra Oncology, Inc. entered the Exit Mode archive.
- Buyer
- GSK plc
- Target
- Sierra Oncology, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Keep browsing